中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
23期
1532-1535
,共4页
林金銮%王发圣%叶君健%吴朝阳%李祥%林建华
林金鑾%王髮聖%葉君健%吳朝暘%李祥%林建華
림금란%왕발골%협군건%오조양%리상%림건화
miR-17-92基因簇%骨肉瘤%预后
miR-17-92基因簇%骨肉瘤%預後
miR-17-92기인족%골육류%예후
miR-17-92 cluster%osteosarcoma%prognosis
目的:探讨人骨肉瘤组织和邻近正常骨组织中miR-17-92基因簇的表达情况及其临床意义。方法:运用Q-PCR法检测63例骨肉瘤组织及邻近部位正常骨组织中miR-17-92基因簇的表达水平,并分析miR-17-92基因簇表达与患者临床病理特征及预后的关系。结果:miR-17-92在所有组织中均有表达,且在肿瘤组织中表达明显高于在正常组织中的表达(P<0.05),另外, miR-17-92基因簇高表达患者预后更差,差异有统计学意义(P=0.027)。结论:miR-17-92基因簇在骨肉瘤组织和邻近正常骨组织中表达存在差异性,可能在骨肉瘤发生、发展过程中起重要作用,有望成为骨肉瘤患者预后一种新的指标。
目的:探討人骨肉瘤組織和鄰近正常骨組織中miR-17-92基因簇的錶達情況及其臨床意義。方法:運用Q-PCR法檢測63例骨肉瘤組織及鄰近部位正常骨組織中miR-17-92基因簇的錶達水平,併分析miR-17-92基因簇錶達與患者臨床病理特徵及預後的關繫。結果:miR-17-92在所有組織中均有錶達,且在腫瘤組織中錶達明顯高于在正常組織中的錶達(P<0.05),另外, miR-17-92基因簇高錶達患者預後更差,差異有統計學意義(P=0.027)。結論:miR-17-92基因簇在骨肉瘤組織和鄰近正常骨組織中錶達存在差異性,可能在骨肉瘤髮生、髮展過程中起重要作用,有望成為骨肉瘤患者預後一種新的指標。
목적:탐토인골육류조직화린근정상골조직중miR-17-92기인족적표체정황급기림상의의。방법:운용Q-PCR법검측63례골육류조직급린근부위정상골조직중miR-17-92기인족적표체수평,병분석miR-17-92기인족표체여환자림상병리특정급예후적관계。결과:miR-17-92재소유조직중균유표체,차재종류조직중표체명현고우재정상조직중적표체(P<0.05),령외, miR-17-92기인족고표체환자예후경차,차이유통계학의의(P=0.027)。결론:miR-17-92기인족재골육류조직화린근정상골조직중표체존재차이성,가능재골육류발생、발전과정중기중요작용,유망성위골육류환자예후일충신적지표。
Objective:To determine the expression of miR-17-92 cluster in osteosarcoma tissue samples and explore its associa-tion with clinical significance. Methods: Quantitative polymerase chain reactiom analysis was used to examine the expression of miR-17-92 cluster in osteosarcoma tissues. Normal bone tissues from 63 patients were matched, and the relationships between the ex-pression of miR-17-92 cluster and the clinicopathological features and prognosis of osteosarcoma were explored. Results:The relative expression of miR-17-92 cluster in osteosarcoma tissues was significantly higher than those in adjacent normal tissues (P<0.05). The high expression of miR-17-92 had a significant correlation with reduced survival (P=0.027). Conclusion:The expression of miR-17-92 cluster closely correlates with the occurrence and progress of osteosarcoma and may be used as an indicator for osteosarcoma prognosis.